Patents by Inventor Annemarie Maier

Annemarie Maier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9969674
    Abstract: The present invention relates to novel compounds, e.g. for use as a medicament. In particular, the present invention relates to novel prodrugs of monomethyl fumarate (MMF) suitable as a medicament, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, inflammatory diseases, for example multiple sclerosis, rheumatoid arthritis and psoriasis.
    Type: Grant
    Filed: April 16, 2015
    Date of Patent: May 15, 2018
    Assignee: ratiopharm GmbH
    Inventors: Wolfgang Albrecht, Roland Selig, Frank Lehmann, Richard Guserle, Annemarie Maier
  • Patent number: 9868690
    Abstract: The present invention relates to novel compounds for use as a medicament. In particular, the present invention relates to novel prodrugs of monomethyl fumarate (MMF) suitable as a medicament, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, inflammatory diseases, for example multiple sclerosis and psoriasis.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: January 16, 2018
    Assignee: ratiopharm GmbH
    Inventors: Wolfgang Albrecht, Roland Selig, Sebastian Rabe, Richard Guserle, Annemarie Maier
  • Patent number: 9796659
    Abstract: The present invention relates to novel compounds, e.g. for use as a medicament. In particular, the present invention relates to novel prodrugs of monomethyl fumarate (MMF) suitable as a medicament, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, inflammatory diseases, for example multiple sclerosis and psoriasis.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: October 24, 2017
    Assignee: ratiopharm GmbH
    Inventors: Wolfgang Albrecht, Frank Lehmann, Roland Selig, Sebastian Rabe, Annemarie Maier, Richard Guserle
  • Patent number: 9663480
    Abstract: The present invention relates to novel compounds, e.g. for use as a medicament. In particular, the present invention relates to novel medicaments, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, or inflammatory diseases, for example multiple sclerosis and psoriasis.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: May 30, 2017
    Assignee: ratiopharm GmbH
    Inventors: Wolfgang Albrecht, Roland Selig, Sebastian Rabe, Annemarie Maier, Richard Guserle
  • Patent number: 9593068
    Abstract: The present invention relates to novel compounds, e.g. for use as a medicament. In particular, the present invention relates to novel medicaments, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, and/or inflammatory diseases, for example multiple sclerosis and psoriasis.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: March 14, 2017
    Assignee: ratiopharm GmbH
    Inventors: Wolfgang Albrecht, Roland Selig, Sebastian Rabe, Annemarie Maier, Richard Guserle
  • Publication number: 20170029357
    Abstract: The present invention relates to novel compounds, e.g. for use as a medicament. In particular, the present invention relates to novel prodrugs of monomethyl fumarate (MMF) suitable as a medicament, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, inflammatory diseases, for example multiple sclerosis, rheumatoid arthritis and psoriasis.
    Type: Application
    Filed: April 16, 2015
    Publication date: February 2, 2017
    Inventors: Wolfgang ALBRECHT, Roland SELIG, Frank LEHMANN, Richard GUSERLE, Annemarie MAIER
  • Publication number: 20170001945
    Abstract: The present invention relates to novel compounds, e.g. for use as a medicament. In particular, the present invention relates to novel prodrugs of monomethyl fumarate (MMF) suitable as a medicament, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, inflammatory diseases, for example multiple sclerosis and psoriasis.
    Type: Application
    Filed: February 27, 2015
    Publication date: January 5, 2017
    Inventors: Wolfgang ALBRECHT, Frank LEHMANN, Roland SELIG, Sebastian RABE, Annemarie MAIER, Richard GUSERLE
  • Publication number: 20160326090
    Abstract: The present invention relates to novel compounds, e.g. for use as a medicament. In particular, the present invention relates to novel medicaments, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, and/or inflammatory diseases, for example multiple sclerosis and psoriasis.
    Type: Application
    Filed: December 4, 2014
    Publication date: November 10, 2016
    Applicant: RATIOPHARM GMBH
    Inventors: Wolfgang ALBRECHT, Roland SELIG, Sebastian RABE, Annemarie MAIER, Richard GUSERLE
  • Publication number: 20160289201
    Abstract: The present invention relates to novel compounds, e.g. for use as a medicament. In particular, the present invention relates to novel medicaments, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, or inflammatory diseases, for example multiple sclerosis and psoriasis.
    Type: Application
    Filed: December 4, 2014
    Publication date: October 6, 2016
    Applicant: Ratiopharm GMBH
    Inventors: Wolfgang ALBRECHT, Roland SELIG, Sebastian RABE, Annemarie MAIER, Richard GUSERLE
  • Publication number: 20160214948
    Abstract: The present invention relates to novel compounds for use as a medicament. In particular, the present invention relates to a medicament, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, inflammatory diseases, for example multiple sclerosis and psoriasis.
    Type: Application
    Filed: December 20, 2013
    Publication date: July 28, 2016
    Inventors: Wolfgang ALBRECHT, Roland SELIG, Sebastian RABE, Richard GUSERLE, Annemarie MAIER
  • Publication number: 20150299103
    Abstract: The present invention relates to novel compounds for use as a medicament. In particular, the present invention relates to novel prodrugs of monomethyl fumarate (MMF) suitable as a medicament, preferably in the treatment and/or prevention of systemic diseases, autoimmune diseases, inflammatory diseases, for example multiple sclerosis and psoriasis.
    Type: Application
    Filed: December 20, 2013
    Publication date: October 22, 2015
    Inventors: Wolfgang ALBRECHT, Roland SELIG, Sebastian RABE, Richard GUSERLE, Annemarie MAIER
  • Publication number: 20150232457
    Abstract: Crystalline forms of Afatinib di-maleate are described in the present application and processes for their preparation. The present invention also includes pharmaceutical compositions of such crystalline forms of Afatinib di-maleate, methods of their preparation and the use thereof hi the treatment of a patient in need thereof. The present invention also describes preparing Afatinib free base and salts of Afatinib, other than Afatibin di-maleate, and solid forms thereof.
    Type: Application
    Filed: April 25, 2012
    Publication date: August 20, 2015
    Applicant: RATIOPHARM GMBH
    Inventors: Anja Bruns, Simone Eichner, Frank Lehmann, Wolfgang Albrecht, Annemarie Maier